Informed consent in randomized quality improvement trials: a critical barrier for learning health systems

JAMA Intern Med. 2014 May;174(5):668-70. doi: 10.1001/jamainternmed.2013.13297.

Authors

Mark J Pletcher¹, Bernard Lo², Deborah Grady³

Affiliations

¹ Department of Epidemiology and Biostatistics, University of California, San Francisco2Department of Medicine, University of California, San Francisco3Clinical and Translational Science Institute, University of California, San Francisco.
² The Greenwall Foundation, New York, New York.
³ Department of Medicine, University of California, San Francisco3Clinical and Translational Science Institute, University of California, San Francisco.

PMID: 24615554
DOI: 10.1001/jamainternmed.2013.13297

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Female
Humans
Male
Smoking Cessation / methods*
Telemedicine / organization & administration*
Tobacco Use Disorder / therapy*

Grants and funding

UL1 TR000004/TR/NCATS NIH HHS/United States